A. Cecil

发表

Modelling antibiotic and cytotoxic isoquinoline effects in Staphylococcus aureus, Staphylococcus epidermidis and mammalian cells.

P. François, J. Schrenzel, T. Dandekar, 2015, International journal of medical microbiology : IJMM.

Influence of breast cancer risk factors on proliferation and DNA damage in human breast glandular tissues: role of intracellular estrogen levels, oxidative stress and estrogen biotransformation

Leo N. Geppert, K. Ickstadt, T. Dandekar, 2021, Archives of toxicology.

Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma

Michael L. Wang, E. Bone, J. Westin, 2021, Leukemia & lymphoma.

Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling

T. Dandekar, S. Rahlfs, K. Becker, 2012, Bioinformatics and biology insights.

Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

I. Gentschev, A. Szalay, A. Frentzen, 2015, Viruses.

Tumor Colonization and Therapy by Escherichia coli Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome

I. Gentschev, A. Szalay, A. Cecil, 2022, Cancers.

Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

P. Townsend, S. Shuttleworth, C. Tomassi, 2009, Progress in medicinal chemistry.

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

I. Wistuba, D. Vining, A. Tsimberidou, 2021, Clinical Cancer Research.

The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.

A. Ganesan, G. Packham, Minoru Yoshida, 2007, Journal of medicinal chemistry.

The drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development

Thomas Dandekar, Chunguang Liang, Meik Kunz, 2016, Database J. Biol. Databases Curation.

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

P. Workman, P. Clarke, F. Raynaud, 2011, Current medicinal chemistry.

Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.

P. Townsend, S. Shuttleworth, R. Harrison, 2011, Progress in medicinal chemistry.

Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells

Jörg Bernhardt, Chunguang Liang, Thomas Dandekar, 2011, Genome Biology.

Antigen profiling analysis of vaccinia virus injected canine tumors

T. Dandekar, I. Nolte, I. Gentschev, 2014, Bioengineered.

Anti-trypanosomal activities and structural chemical properties of selected compound classes

Christoph A. Sotriffer, Georg Krohne, Markus Engstler, 2015, Parasitology Research.

Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models

T. Dandekar, I. Gentschev, A. Szalay, 2019, Bioengineered.

Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells

T. Dandekar, Chunguang Liang, J. Bernhardt, 2011, Genome Biology.